Navigation Links
No Lymphoma Risk From Rheumatoid Arthritis Drugs

There has been an increasing fear regarding the elevated risk of lymphoma associated with rheumatoid arthritis treatment// A new study by Swedish researchers has found that such treatments may not confer an increased susceptibility to cancer, the results of which can be seen in the latest issue of Arthritis & Rheumatism journal.

The risk of cancer has been found to increase with worsening of the chronic inflammatory process. In other words, a cause-effect relationship has been established with the disease severity and cancer risk. Infact the drugs given for symptomatic treatment of rheumatoid arthritis, which, prevent further progress of the inflammation may actually reduce the cancer risk.

Rheumatoid arthritis is a progressive disease, characterized by inflammation of joints resulting in pain, joint damage, immobility and finally disability. Nearly 2 million Americans have been diagnosed with the chronic disease, according to estimates by the Arthritis Foundation. Non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologic response modifiers (new generation drugs) and analgesics are currently being given for treatment.

The researchers studied data obtained from nearly 75,000 rheumatoid arthritis patients. Amongst these, 378 patients developed lymphoma during the course of treatment. The data obtained was compared with that obtained from 378 healthy controls. The severity of the disease (low, medium, high), the duration of the disease, the level of inflammation or tenderness in the joints was some of the factors taken into consideration.

The results of the analysis established that individuals with high activity (severe disease) had a 70-fold increased risk of developing lymphoma. The severity of involvement of knees, hands and feet within the first year of diagnosis was also found to confer an increased risk. The lymphoma risk was much lower (8 fold) in those who ha d medium disease activity.

Furthermore, no increased risk of lymphoma was found in those who were given anti-rheumatic drugs (DMARDS), including the drug methotrexate (anti-cancer drug). No increased risk could also be documented with use of steroids or NSAIDs. Surprisingly, the incidence of lymphoma in those who were given corticosteriods injections was the lowest, probably highlighting its role in cancer prevention.

The results of the present study highlight the need for early identification and aggressive treatment to prevent worsening of the disease. To conclude, the more severe the disease, the higher is the cancer risk. The provision of appropriate anti-rheumatic treatment can decrease the disease related complications.


'"/>




Related medicine news :

1. Lymphomas Link to Hepatitis C
2. New Guidelines For Assessing Lymphoma Treatment
3. A Novel Treatment for KSHV-infected Lymphomas
4. New treatment for Rheumatoid Arthritis
5. New Rheumatoid Arthritis Treatment
6. New Rheumatoid Arthritis Treatment
7. Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis
8. The Link Between Rheumatoid Arthritis And Heart Failure
9. Smoking during pregnancy increases risk of Rheumatoid Arthritis.
10. Good News For Those Of You Suffering From Rheumatoid Arthritis
11. Mineral Oil exposure increases risk of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
Breaking Medicine Technology: